SONOMA PHARMACEUTICALS, INC. (SNOA) Shareholders’ equity 2017–2026
SONOMA PHARMACEUTICALS, INC. (SNOA) shareholders’ equity at each fiscal year-end, per SEC filings.
$3.1MFY2026 · since FY2017: $21.4M → $3.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $3.1M | -29.8% |
| FY2025 | $4.4M | -28.1% |
| FY2024 | $6.1M | -23.1% |
| FY2023 | $8.0M | -8.3% |
| FY2022 | $8.7M | +62.2% |
| FY2021 | $5.4M | -4.6% |
| FY2020 | $5.6M | -27.6% |
| FY2019 | $7.8M | -49.3% |
| FY2018 | $15.3M | -28.5% |
| FY2017 | $21.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice